Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

EFTR

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EFTR
DateTimeSourceHeadlineSymbolCompany
22/02/202409:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
22/02/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
10/02/202412:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EFTReFFECTOR Therapeutics Inc
31/01/202400:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
27/01/202408:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
27/01/202408:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
11/01/202400:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
11/01/202400:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
09/01/202400:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
09/01/202400:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
09/12/202300:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
09/12/202300:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
29/11/202300:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
29/11/202300:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
14/11/202308:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
14/11/202308:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
12/09/202306:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
12/09/202306:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202306:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202306:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202306:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202306:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
05/08/202306:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
05/08/202306:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
05/08/202306:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
27/06/202320:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EFTReFFECTOR Therapeutics Inc
24/06/202306:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202320:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202320:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202320:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EFTReFFECTOR Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EFTR